nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—SLCO1B3—Cabazitaxel—prostate cancer	0.0911	0.131	CbGbCtD
Gadoxetate—ABCC3—Conjugated Estrogens—prostate cancer	0.0656	0.0946	CbGbCtD
Gadoxetate—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0583	0.084	CbGbCtD
Gadoxetate—SLCO1B1—Cabazitaxel—prostate cancer	0.0531	0.0765	CbGbCtD
Gadoxetate—SLCO1B1—Estrone—prostate cancer	0.0519	0.0748	CbGbCtD
Gadoxetate—SLCO1B3—Estradiol—prostate cancer	0.0512	0.0737	CbGbCtD
Gadoxetate—ABCC4—Conjugated Estrogens—prostate cancer	0.0501	0.0723	CbGbCtD
Gadoxetate—ABCC2—Ethinyl Estradiol—prostate cancer	0.0406	0.0586	CbGbCtD
Gadoxetate—ABCC3—Etoposide—prostate cancer	0.0376	0.0542	CbGbCtD
Gadoxetate—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0339	0.0489	CbGbCtD
Gadoxetate—SLCO1B3—Docetaxel—prostate cancer	0.0306	0.0441	CbGbCtD
Gadoxetate—ABCC2—Conjugated Estrogens—prostate cancer	0.0298	0.043	CbGbCtD
Gadoxetate—SLCO1B1—Estradiol—prostate cancer	0.0298	0.0429	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—prostate cancer	0.0257	0.037	CbGbCtD
Gadoxetate—ABCC2—Etoposide—prostate cancer	0.0171	0.0246	CbGbCtD
Gadoxetate—ABCC2—Docetaxel—prostate cancer	0.0156	0.0225	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—prostate cancer	0.0117	0.0168	CbGbCtD
Gadoxetate—ABCC3—prostate gland—prostate cancer	0.000392	0.132	CbGeAlD
Gadoxetate—ABCC4—prostate gland—prostate cancer	0.000323	0.109	CbGeAlD
Gadoxetate—ABCC2—prostate gland—prostate cancer	0.000313	0.106	CbGeAlD
Gadoxetate—SLCO1B1—renal system—prostate cancer	0.000281	0.0951	CbGeAlD
Gadoxetate—ABCC3—renal system—prostate cancer	0.000267	0.0903	CbGeAlD
Gadoxetate—ABCC4—renal system—prostate cancer	0.00022	0.0745	CbGeAlD
Gadoxetate—ABCC2—renal system—prostate cancer	0.000213	0.0721	CbGeAlD
Gadoxetate—ABCC3—testis—prostate cancer	0.000173	0.0583	CbGeAlD
Gadoxetate—ABCC4—bone marrow—prostate cancer	0.000167	0.0563	CbGeAlD
Gadoxetate—ABCC4—testis—prostate cancer	0.000142	0.0482	CbGeAlD
Gadoxetate—ABCC2—testis—prostate cancer	0.000138	0.0466	CbGeAlD
Gadoxetate—ABCC3—lymph node—prostate cancer	0.000125	0.0423	CbGeAlD
Gadoxetate—ABCC4—lymph node—prostate cancer	0.000103	0.0349	CbGeAlD
Gadoxetate—ABCC2—lymph node—prostate cancer	9.99e-05	0.0338	CbGeAlD
Gadoxetate—Dry mouth—Docetaxel—prostate cancer	5.62e-05	0.000256	CcSEcCtD
Gadoxetate—Chest pain—Capecitabine—prostate cancer	5.56e-05	0.000253	CcSEcCtD
Gadoxetate—Anxiety—Capecitabine—prostate cancer	5.54e-05	0.000252	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	5.52e-05	0.000252	CcSEcCtD
Gadoxetate—Oedema—Docetaxel—prostate cancer	5.51e-05	0.000251	CcSEcCtD
Gadoxetate—Anaphylactic shock—Docetaxel—prostate cancer	5.51e-05	0.000251	CcSEcCtD
Gadoxetate—Discomfort—Capecitabine—prostate cancer	5.5e-05	0.00025	CcSEcCtD
Gadoxetate—Vision blurred—Prednisone—prostate cancer	5.49e-05	0.00025	CcSEcCtD
Gadoxetate—Infection—Docetaxel—prostate cancer	5.47e-05	0.000249	CcSEcCtD
Gadoxetate—Feeling abnormal—Etoposide—prostate cancer	5.46e-05	0.000249	CcSEcCtD
Gadoxetate—Diarrhoea—Mitoxantrone—prostate cancer	5.45e-05	0.000248	CcSEcCtD
Gadoxetate—Dry mouth—Capecitabine—prostate cancer	5.44e-05	0.000248	CcSEcCtD
Gadoxetate—Vomiting—Estradiol—prostate cancer	5.44e-05	0.000248	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Etoposide—prostate cancer	5.42e-05	0.000247	CcSEcCtD
Gadoxetate—Shock—Docetaxel—prostate cancer	5.42e-05	0.000247	CcSEcCtD
Gadoxetate—Nervous system disorder—Docetaxel—prostate cancer	5.4e-05	0.000246	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisone—prostate cancer	5.4e-05	0.000246	CcSEcCtD
Gadoxetate—Rash—Estradiol—prostate cancer	5.39e-05	0.000245	CcSEcCtD
Gadoxetate—Dermatitis—Estradiol—prostate cancer	5.39e-05	0.000245	CcSEcCtD
Gadoxetate—Tachycardia—Docetaxel—prostate cancer	5.38e-05	0.000245	CcSEcCtD
Gadoxetate—Headache—Estradiol—prostate cancer	5.36e-05	0.000244	CcSEcCtD
Gadoxetate—Skin disorder—Docetaxel—prostate cancer	5.35e-05	0.000244	CcSEcCtD
Gadoxetate—Agitation—Prednisone—prostate cancer	5.35e-05	0.000244	CcSEcCtD
Gadoxetate—Oedema—Capecitabine—prostate cancer	5.33e-05	0.000243	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—prostate cancer	5.3e-05	0.000241	CcSEcCtD
Gadoxetate—Infection—Capecitabine—prostate cancer	5.3e-05	0.000241	CcSEcCtD
Gadoxetate—Urticaria—Etoposide—prostate cancer	5.27e-05	0.00024	CcSEcCtD
Gadoxetate—Anorexia—Docetaxel—prostate cancer	5.25e-05	0.000239	CcSEcCtD
Gadoxetate—Malaise—Prednisone—prostate cancer	5.25e-05	0.000239	CcSEcCtD
Gadoxetate—Shock—Capecitabine—prostate cancer	5.25e-05	0.000239	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—prostate cancer	5.24e-05	0.000239	CcSEcCtD
Gadoxetate—Abdominal pain—Etoposide—prostate cancer	5.24e-05	0.000239	CcSEcCtD
Gadoxetate—Body temperature increased—Etoposide—prostate cancer	5.24e-05	0.000239	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—prostate cancer	5.24e-05	0.000239	CcSEcCtD
Gadoxetate—Nervous system disorder—Capecitabine—prostate cancer	5.23e-05	0.000238	CcSEcCtD
Gadoxetate—Vertigo—Prednisone—prostate cancer	5.23e-05	0.000238	CcSEcCtD
Gadoxetate—Syncope—Prednisone—prostate cancer	5.22e-05	0.000238	CcSEcCtD
Gadoxetate—Tachycardia—Capecitabine—prostate cancer	5.2e-05	0.000237	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—prostate cancer	5.2e-05	0.000237	CcSEcCtD
Gadoxetate—Skin disorder—Capecitabine—prostate cancer	5.18e-05	0.000236	CcSEcCtD
Gadoxetate—Hyperhidrosis—Capecitabine—prostate cancer	5.16e-05	0.000235	CcSEcCtD
Gadoxetate—Hypotension—Docetaxel—prostate cancer	5.15e-05	0.000234	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—prostate cancer	5.14e-05	0.000234	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisone—prostate cancer	5.12e-05	0.000233	CcSEcCtD
Gadoxetate—Anorexia—Capecitabine—prostate cancer	5.08e-05	0.000231	CcSEcCtD
Gadoxetate—Nausea—Estradiol—prostate cancer	5.08e-05	0.000231	CcSEcCtD
Gadoxetate—Vomiting—Mitoxantrone—prostate cancer	5.07e-05	0.000231	CcSEcCtD
Gadoxetate—Convulsion—Prednisone—prostate cancer	5.04e-05	0.00023	CcSEcCtD
Gadoxetate—Rash—Mitoxantrone—prostate cancer	5.02e-05	0.000229	CcSEcCtD
Gadoxetate—Dermatitis—Mitoxantrone—prostate cancer	5.02e-05	0.000229	CcSEcCtD
Gadoxetate—Headache—Mitoxantrone—prostate cancer	4.99e-05	0.000227	CcSEcCtD
Gadoxetate—Hypotension—Capecitabine—prostate cancer	4.98e-05	0.000227	CcSEcCtD
Gadoxetate—Paraesthesia—Docetaxel—prostate cancer	4.95e-05	0.000225	CcSEcCtD
Gadoxetate—Anxiety—Prednisone—prostate cancer	4.94e-05	0.000225	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.92e-05	0.000224	CcSEcCtD
Gadoxetate—Dyspnoea—Docetaxel—prostate cancer	4.91e-05	0.000224	CcSEcCtD
Gadoxetate—Discomfort—Prednisone—prostate cancer	4.9e-05	0.000223	CcSEcCtD
Gadoxetate—Hypersensitivity—Etoposide—prostate cancer	4.88e-05	0.000222	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—prostate cancer	4.85e-05	0.000221	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—prostate cancer	4.85e-05	0.000221	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—prostate cancer	4.85e-05	0.000221	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—prostate cancer	4.81e-05	0.000219	CcSEcCtD
Gadoxetate—Paraesthesia—Capecitabine—prostate cancer	4.79e-05	0.000218	CcSEcCtD
Gadoxetate—Decreased appetite—Docetaxel—prostate cancer	4.79e-05	0.000218	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Docetaxel—prostate cancer	4.76e-05	0.000217	CcSEcCtD
Gadoxetate—Asthenia—Etoposide—prostate cancer	4.76e-05	0.000217	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—prostate cancer	4.75e-05	0.000216	CcSEcCtD
Gadoxetate—Dyspnoea—Capecitabine—prostate cancer	4.75e-05	0.000216	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisone—prostate cancer	4.75e-05	0.000216	CcSEcCtD
Gadoxetate—Oedema—Prednisone—prostate cancer	4.75e-05	0.000216	CcSEcCtD
Gadoxetate—Fatigue—Docetaxel—prostate cancer	4.75e-05	0.000216	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—prostate cancer	4.74e-05	0.000216	CcSEcCtD
Gadoxetate—Nausea—Mitoxantrone—prostate cancer	4.73e-05	0.000215	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—prostate cancer	4.72e-05	0.000215	CcSEcCtD
Gadoxetate—Infection—Prednisone—prostate cancer	4.72e-05	0.000215	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—prostate cancer	4.71e-05	0.000215	CcSEcCtD
Gadoxetate—Constipation—Docetaxel—prostate cancer	4.71e-05	0.000214	CcSEcCtD
Gadoxetate—Chills—Epirubicin—prostate cancer	4.69e-05	0.000214	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—prostate cancer	4.69e-05	0.000213	CcSEcCtD
Gadoxetate—Shock—Prednisone—prostate cancer	4.67e-05	0.000213	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—prostate cancer	4.67e-05	0.000213	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—prostate cancer	4.66e-05	0.000212	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—prostate cancer	4.64e-05	0.000211	CcSEcCtD
Gadoxetate—Decreased appetite—Capecitabine—prostate cancer	4.64e-05	0.000211	CcSEcCtD
Gadoxetate—Skin disorder—Prednisone—prostate cancer	4.61e-05	0.00021	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Capecitabine—prostate cancer	4.6e-05	0.00021	CcSEcCtD
Gadoxetate—Fatigue—Capecitabine—prostate cancer	4.6e-05	0.000209	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisone—prostate cancer	4.59e-05	0.000209	CcSEcCtD
Gadoxetate—Constipation—Capecitabine—prostate cancer	4.56e-05	0.000208	CcSEcCtD
Gadoxetate—Feeling abnormal—Docetaxel—prostate cancer	4.54e-05	0.000207	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—prostate cancer	4.53e-05	0.000206	CcSEcCtD
Gadoxetate—Anorexia—Prednisone—prostate cancer	4.53e-05	0.000206	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Docetaxel—prostate cancer	4.5e-05	0.000205	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—prostate cancer	4.49e-05	0.000204	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—prostate cancer	4.49e-05	0.000204	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—prostate cancer	4.49e-05	0.000204	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—prostate cancer	4.46e-05	0.000203	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—prostate cancer	4.4e-05	0.0002	CcSEcCtD
Gadoxetate—Feeling abnormal—Capecitabine—prostate cancer	4.39e-05	0.0002	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—prostate cancer	4.39e-05	0.0002	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—prostate cancer	4.38e-05	0.0002	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—prostate cancer	4.37e-05	0.000199	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Capecitabine—prostate cancer	4.36e-05	0.000199	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—prostate cancer	4.36e-05	0.000199	CcSEcCtD
Gadoxetate—Abdominal pain—Docetaxel—prostate cancer	4.35e-05	0.000198	CcSEcCtD
Gadoxetate—Body temperature increased—Docetaxel—prostate cancer	4.35e-05	0.000198	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—prostate cancer	4.34e-05	0.000198	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—prostate cancer	4.32e-05	0.000197	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—prostate cancer	4.29e-05	0.000195	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—prostate cancer	4.27e-05	0.000194	CcSEcCtD
Gadoxetate—Urticaria—Capecitabine—prostate cancer	4.24e-05	0.000193	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—prostate cancer	4.22e-05	0.000192	CcSEcCtD
Gadoxetate—Abdominal pain—Capecitabine—prostate cancer	4.22e-05	0.000192	CcSEcCtD
Gadoxetate—Body temperature increased—Capecitabine—prostate cancer	4.22e-05	0.000192	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—prostate cancer	4.21e-05	0.000192	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—prostate cancer	4.18e-05	0.00019	CcSEcCtD
Gadoxetate—Rash—Etoposide—prostate cancer	4.18e-05	0.00019	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—prostate cancer	4.18e-05	0.00019	CcSEcCtD
Gadoxetate—Headache—Etoposide—prostate cancer	4.15e-05	0.000189	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—prostate cancer	4.15e-05	0.000189	CcSEcCtD
Gadoxetate—Decreased appetite—Prednisone—prostate cancer	4.13e-05	0.000188	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—prostate cancer	4.12e-05	0.000188	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—prostate cancer	4.11e-05	0.000187	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—prostate cancer	4.1e-05	0.000186	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—prostate cancer	4.09e-05	0.000186	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—prostate cancer	4.08e-05	0.000186	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—prostate cancer	4.07e-05	0.000185	CcSEcCtD
Gadoxetate—Constipation—Prednisone—prostate cancer	4.06e-05	0.000185	CcSEcCtD
Gadoxetate—Hypersensitivity—Docetaxel—prostate cancer	4.06e-05	0.000185	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—prostate cancer	4.02e-05	0.000183	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—prostate cancer	4e-05	0.000182	CcSEcCtD
Gadoxetate—Cough—Epirubicin—prostate cancer	3.97e-05	0.000181	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—prostate cancer	3.97e-05	0.000181	CcSEcCtD
Gadoxetate—Asthenia—Docetaxel—prostate cancer	3.95e-05	0.00018	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—prostate cancer	3.94e-05	0.00018	CcSEcCtD
Gadoxetate—Nausea—Etoposide—prostate cancer	3.94e-05	0.000179	CcSEcCtD
Gadoxetate—Hypersensitivity—Capecitabine—prostate cancer	3.93e-05	0.000179	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisone—prostate cancer	3.91e-05	0.000178	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—prostate cancer	3.91e-05	0.000178	CcSEcCtD
Gadoxetate—Pruritus—Docetaxel—prostate cancer	3.9e-05	0.000177	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—prostate cancer	3.88e-05	0.000177	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—prostate cancer	3.88e-05	0.000176	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—prostate cancer	3.87e-05	0.000176	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—prostate cancer	3.86e-05	0.000176	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.85e-05	0.000175	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—prostate cancer	3.83e-05	0.000174	CcSEcCtD
Gadoxetate—Asthenia—Capecitabine—prostate cancer	3.83e-05	0.000174	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—prostate cancer	3.8e-05	0.000173	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—prostate cancer	3.79e-05	0.000173	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—prostate cancer	3.78e-05	0.000172	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—prostate cancer	3.78e-05	0.000172	CcSEcCtD
Gadoxetate—Urticaria—Prednisone—prostate cancer	3.77e-05	0.000172	CcSEcCtD
Gadoxetate—Pruritus—Capecitabine—prostate cancer	3.77e-05	0.000172	CcSEcCtD
Gadoxetate—Diarrhoea—Docetaxel—prostate cancer	3.77e-05	0.000172	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—prostate cancer	3.76e-05	0.000171	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—prostate cancer	3.76e-05	0.000171	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—prostate cancer	3.72e-05	0.000169	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—prostate cancer	3.72e-05	0.000169	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—prostate cancer	3.72e-05	0.000169	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—prostate cancer	3.7e-05	0.000169	CcSEcCtD
Gadoxetate—Infection—Epirubicin—prostate cancer	3.69e-05	0.000168	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—prostate cancer	3.68e-05	0.000167	CcSEcCtD
Gadoxetate—Shock—Epirubicin—prostate cancer	3.66e-05	0.000166	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—prostate cancer	3.65e-05	0.000166	CcSEcCtD
Gadoxetate—Diarrhoea—Capecitabine—prostate cancer	3.65e-05	0.000166	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—prostate cancer	3.64e-05	0.000166	CcSEcCtD
Gadoxetate—Dizziness—Docetaxel—prostate cancer	3.64e-05	0.000166	CcSEcCtD
Gadoxetate—Tachycardia—Epirubicin—prostate cancer	3.63e-05	0.000165	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—prostate cancer	3.61e-05	0.000164	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—prostate cancer	3.59e-05	0.000164	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—prostate cancer	3.59e-05	0.000163	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—prostate cancer	3.57e-05	0.000163	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.56e-05	0.000162	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—prostate cancer	3.54e-05	0.000161	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—prostate cancer	3.54e-05	0.000161	CcSEcCtD
Gadoxetate—Dizziness—Capecitabine—prostate cancer	3.53e-05	0.000161	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—prostate cancer	3.51e-05	0.00016	CcSEcCtD
Gadoxetate—Vomiting—Docetaxel—prostate cancer	3.5e-05	0.000159	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisone—prostate cancer	3.5e-05	0.000159	CcSEcCtD
Gadoxetate—Rash—Docetaxel—prostate cancer	3.47e-05	0.000158	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—prostate cancer	3.47e-05	0.000158	CcSEcCtD
Gadoxetate—Dermatitis—Docetaxel—prostate cancer	3.47e-05	0.000158	CcSEcCtD
Gadoxetate—Headache—Docetaxel—prostate cancer	3.45e-05	0.000157	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—prostate cancer	3.44e-05	0.000157	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—prostate cancer	3.44e-05	0.000157	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—prostate cancer	3.42e-05	0.000155	CcSEcCtD
Gadoxetate—Asthenia—Prednisone—prostate cancer	3.41e-05	0.000155	CcSEcCtD
Gadoxetate—Vomiting—Capecitabine—prostate cancer	3.39e-05	0.000154	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—prostate cancer	3.38e-05	0.000154	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—prostate cancer	3.37e-05	0.000153	CcSEcCtD
Gadoxetate—Rash—Capecitabine—prostate cancer	3.36e-05	0.000153	CcSEcCtD
Gadoxetate—Pruritus—Prednisone—prostate cancer	3.36e-05	0.000153	CcSEcCtD
Gadoxetate—Dermatitis—Capecitabine—prostate cancer	3.36e-05	0.000153	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—prostate cancer	3.35e-05	0.000153	CcSEcCtD
Gadoxetate—Headache—Capecitabine—prostate cancer	3.34e-05	0.000152	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—prostate cancer	3.34e-05	0.000152	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—prostate cancer	3.34e-05	0.000152	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—prostate cancer	3.32e-05	0.000151	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—prostate cancer	3.31e-05	0.000151	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—prostate cancer	3.28e-05	0.000149	CcSEcCtD
Gadoxetate—Nausea—Docetaxel—prostate cancer	3.27e-05	0.000149	CcSEcCtD
Gadoxetate—Diarrhoea—Prednisone—prostate cancer	3.25e-05	0.000148	CcSEcCtD
Gadoxetate—Decreased appetite—Epirubicin—prostate cancer	3.23e-05	0.000147	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—prostate cancer	3.21e-05	0.000146	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—prostate cancer	3.21e-05	0.000146	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—prostate cancer	3.2e-05	0.000146	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—prostate cancer	3.18e-05	0.000145	CcSEcCtD
Gadoxetate—Nausea—Capecitabine—prostate cancer	3.17e-05	0.000144	CcSEcCtD
Gadoxetate—Dizziness—Prednisone—prostate cancer	3.14e-05	0.000143	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—prostate cancer	3.09e-05	0.000141	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—prostate cancer	3.06e-05	0.00014	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—prostate cancer	3.06e-05	0.000139	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Epirubicin—prostate cancer	3.04e-05	0.000138	CcSEcCtD
Gadoxetate—Vomiting—Prednisone—prostate cancer	3.02e-05	0.000138	CcSEcCtD
Gadoxetate—Rash—Prednisone—prostate cancer	3e-05	0.000136	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—prostate cancer	2.99e-05	0.000136	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—prostate cancer	2.99e-05	0.000136	CcSEcCtD
Gadoxetate—Headache—Prednisone—prostate cancer	2.98e-05	0.000135	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.97e-05	0.000135	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—prostate cancer	2.96e-05	0.000135	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—prostate cancer	2.95e-05	0.000134	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—prostate cancer	2.94e-05	0.000134	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—prostate cancer	2.94e-05	0.000134	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—prostate cancer	2.94e-05	0.000134	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—prostate cancer	2.83e-05	0.000129	CcSEcCtD
Gadoxetate—Nausea—Prednisone—prostate cancer	2.82e-05	0.000128	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—prostate cancer	2.81e-05	0.000128	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—prostate cancer	2.74e-05	0.000125	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—prostate cancer	2.73e-05	0.000124	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—prostate cancer	2.72e-05	0.000124	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—prostate cancer	2.72e-05	0.000124	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—SULT1A1—prostate cancer	2.67e-05	0.000319	CbGpPWpGaD
Gadoxetate—Asthenia—Epirubicin—prostate cancer	2.67e-05	0.000121	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.66e-05	0.000318	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SULT1E1—prostate cancer	2.65e-05	0.000317	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SRD5A1—prostate cancer	2.65e-05	0.000317	CbGpPWpGaD
Gadoxetate—Pruritus—Epirubicin—prostate cancer	2.63e-05	0.00012	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—SLC22A1—prostate cancer	2.61e-05	0.000312	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.61e-05	0.000312	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SRC—prostate cancer	2.61e-05	0.000312	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTA1—prostate cancer	2.61e-05	0.000311	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.58e-05	0.000308	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.58e-05	0.000308	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HSD3B2—prostate cancer	2.58e-05	0.000308	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTO1—prostate cancer	2.58e-05	0.000308	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NAT2—prostate cancer	2.58e-05	0.000308	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.57e-05	0.000307	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SULT2A1—prostate cancer	2.55e-05	0.000304	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	2.54e-05	0.000304	CbGpPWpGaD
Gadoxetate—Diarrhoea—Epirubicin—prostate cancer	2.54e-05	0.000116	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.54e-05	0.000303	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Doxorubicin—prostate cancer	2.53e-05	0.000115	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—ACSL4—prostate cancer	2.53e-05	0.000302	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD17B3—prostate cancer	2.53e-05	0.000302	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MED12—prostate cancer	2.5e-05	0.000299	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.5e-05	0.000299	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNG5—prostate cancer	2.48e-05	0.000297	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.48e-05	0.000296	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LRP2—prostate cancer	2.47e-05	0.000295	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PLCB2—prostate cancer	2.47e-05	0.000295	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2C18—prostate cancer	2.47e-05	0.000295	CbGpPWpGaD
Gadoxetate—Asthenia—Doxorubicin—prostate cancer	2.47e-05	0.000112	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PLAU—prostate cancer	2.46e-05	0.000294	CbGpPWpGaD
Gadoxetate—Dizziness—Epirubicin—prostate cancer	2.46e-05	0.000112	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.45e-05	0.000292	CbGpPWpGaD
Gadoxetate—Pruritus—Doxorubicin—prostate cancer	2.43e-05	0.000111	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—ARG2—prostate cancer	2.43e-05	0.00029	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PHGDH—prostate cancer	2.43e-05	0.00029	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UMPS—prostate cancer	2.43e-05	0.00029	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—P4HB—prostate cancer	2.42e-05	0.000289	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.42e-05	0.000288	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.41e-05	0.000288	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CAV1—prostate cancer	2.41e-05	0.000287	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NCOA3—prostate cancer	2.39e-05	0.000286	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LDHB—prostate cancer	2.38e-05	0.000284	CbGpPWpGaD
Gadoxetate—Vomiting—Epirubicin—prostate cancer	2.36e-05	0.000108	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—SLC22A1—prostate cancer	2.36e-05	0.000281	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.36e-05	0.000281	CbGpPWpGaD
Gadoxetate—Diarrhoea—Doxorubicin—prostate cancer	2.35e-05	0.000107	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.35e-05	0.000281	CbGpPWpGaD
Gadoxetate—Rash—Epirubicin—prostate cancer	2.34e-05	0.000107	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—prostate cancer	2.34e-05	0.000107	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—CYP3A5—prostate cancer	2.34e-05	0.000279	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	2.33e-05	0.000279	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.33e-05	0.000278	CbGpPWpGaD
Gadoxetate—Headache—Epirubicin—prostate cancer	2.33e-05	0.000106	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—SULT2A1—prostate cancer	2.3e-05	0.000274	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.3e-05	0.000274	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HPGDS—prostate cancer	2.28e-05	0.000273	CbGpPWpGaD
Gadoxetate—Dizziness—Doxorubicin—prostate cancer	2.27e-05	0.000103	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—CYP2C19—prostate cancer	2.27e-05	0.000271	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MED12—prostate cancer	2.26e-05	0.00027	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PDHA1—prostate cancer	2.26e-05	0.000269	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA3—prostate cancer	2.26e-05	0.000269	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UCP3—prostate cancer	2.26e-05	0.000269	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TCN2—prostate cancer	2.26e-05	0.000269	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNG5—prostate cancer	2.24e-05	0.000268	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—PPARA—prostate cancer	2.22e-05	0.000264	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTT1—prostate cancer	2.21e-05	0.000264	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ACHE—prostate cancer	2.21e-05	0.000264	CbGpPWpGaD
Gadoxetate—Nausea—Epirubicin—prostate cancer	2.21e-05	0.0001	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—prostate cancer	2.19e-05	0.000262	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2A6—prostate cancer	2.19e-05	0.000261	CbGpPWpGaD
Gadoxetate—Vomiting—Doxorubicin—prostate cancer	2.19e-05	9.95e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.18e-05	0.00026	CbGpPWpGaD
Gadoxetate—Rash—Doxorubicin—prostate cancer	2.17e-05	9.87e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—EGF—prostate cancer	2.17e-05	0.000259	CbGpPWpGaD
Gadoxetate—Dermatitis—Doxorubicin—prostate cancer	2.17e-05	9.86e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—NCOA3—prostate cancer	2.16e-05	0.000258	CbGpPWpGaD
Gadoxetate—Headache—Doxorubicin—prostate cancer	2.15e-05	9.8e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—HSD3B1—prostate cancer	2.15e-05	0.000257	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC22A3—prostate cancer	2.15e-05	0.000257	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1C3—prostate cancer	2.13e-05	0.000254	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.12e-05	0.000253	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PRKACB—prostate cancer	2.12e-05	0.000253	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP17A1—prostate cancer	2.1e-05	0.00025	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.09e-05	0.000249	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.07e-05	0.000248	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.07e-05	0.000247	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TBXAS1—prostate cancer	2.06e-05	0.000246	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA4—prostate cancer	2.06e-05	0.000246	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HPGDS—prostate cancer	2.06e-05	0.000246	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2C19—prostate cancer	2.05e-05	0.000244	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—prostate cancer	2.04e-05	9.3e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—CREBBP—prostate cancer	2.03e-05	0.000243	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.02e-05	0.000241	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA2—prostate cancer	2.01e-05	0.00024	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF1—prostate cancer	2.01e-05	0.00024	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTT1—prostate cancer	2e-05	0.000239	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ACHE—prostate cancer	2e-05	0.000239	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NCOA2—prostate cancer	2e-05	0.000239	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCG5—prostate cancer	1.99e-05	0.000237	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SULT1A1—prostate cancer	1.99e-05	0.000237	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.99e-05	0.000237	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2A6—prostate cancer	1.98e-05	0.000236	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.97e-05	0.000235	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA1—prostate cancer	1.94e-05	0.000232	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—prostate cancer	1.93e-05	0.00023	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1C3—prostate cancer	1.92e-05	0.000229	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTO1—prostate cancer	1.92e-05	0.000229	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD3B2—prostate cancer	1.92e-05	0.000229	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NAT2—prostate cancer	1.92e-05	0.000229	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PRKACB—prostate cancer	1.91e-05	0.000228	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC5A5—prostate cancer	1.91e-05	0.000228	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINE1—prostate cancer	1.91e-05	0.000228	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP17A1—prostate cancer	1.89e-05	0.000226	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.87e-05	0.000223	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.87e-05	0.000223	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.87e-05	0.000223	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2E1—prostate cancer	1.86e-05	0.000222	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.85e-05	0.00022	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NQO1—prostate cancer	1.84e-05	0.00022	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PLCB2—prostate cancer	1.84e-05	0.00022	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LRP2—prostate cancer	1.84e-05	0.00022	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2C18—prostate cancer	1.84e-05	0.00022	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS3—prostate cancer	1.82e-05	0.000217	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TH—prostate cancer	1.81e-05	0.000217	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—P4HB—prostate cancer	1.8e-05	0.000215	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NCOA2—prostate cancer	1.8e-05	0.000215	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.8e-05	0.000215	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP3A4—prostate cancer	1.79e-05	0.000214	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.79e-05	0.000213	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—JAK2—prostate cancer	1.77e-05	0.000211	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1B1—prostate cancer	1.76e-05	0.000211	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.76e-05	0.00021	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC22A1—prostate cancer	1.76e-05	0.00021	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.75e-05	0.000209	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.73e-05	0.000207	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC5A5—prostate cancer	1.72e-05	0.000205	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SULT2A1—prostate cancer	1.71e-05	0.000204	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GGT1—prostate cancer	1.71e-05	0.000204	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NCOA1—prostate cancer	1.68e-05	0.000201	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MED12—prostate cancer	1.68e-05	0.000201	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2E1—prostate cancer	1.68e-05	0.000201	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—prostate cancer	1.68e-05	0.000201	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNG5—prostate cancer	1.67e-05	0.000199	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NQO1—prostate cancer	1.66e-05	0.000198	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP19A1—prostate cancer	1.66e-05	0.000198	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TH—prostate cancer	1.64e-05	0.000195	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.63e-05	0.000194	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.62e-05	0.000194	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP3A4—prostate cancer	1.62e-05	0.000193	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.61e-05	0.000192	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOA3—prostate cancer	1.61e-05	0.000192	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RXRA—prostate cancer	1.6e-05	0.000191	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1B1—prostate cancer	1.59e-05	0.00019	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.58e-05	0.000189	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.56e-05	0.000186	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—COMT—prostate cancer	1.54e-05	0.000184	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—prostate cancer	1.54e-05	0.000184	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GGT1—prostate cancer	1.54e-05	0.000184	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTP1—prostate cancer	1.54e-05	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HPGDS—prostate cancer	1.53e-05	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2C19—prostate cancer	1.52e-05	0.000182	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NCOA1—prostate cancer	1.52e-05	0.000181	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ITPR1—prostate cancer	1.51e-05	0.00018	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP19A1—prostate cancer	1.5e-05	0.000179	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ACHE—prostate cancer	1.49e-05	0.000178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTT1—prostate cancer	1.49e-05	0.000178	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.49e-05	0.000177	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.48e-05	0.000177	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2A6—prostate cancer	1.47e-05	0.000176	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.47e-05	0.000175	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RXRA—prostate cancer	1.44e-05	0.000172	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1C3—prostate cancer	1.43e-05	0.000171	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TYMS—prostate cancer	1.43e-05	0.00017	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PRKACB—prostate cancer	1.42e-05	0.00017	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—prostate cancer	1.41e-05	0.000168	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP17A1—prostate cancer	1.41e-05	0.000168	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.41e-05	0.000168	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.39e-05	0.000166	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—COMT—prostate cancer	1.39e-05	0.000166	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.39e-05	0.000166	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTP1—prostate cancer	1.39e-05	0.000165	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LPL—prostate cancer	1.38e-05	0.000165	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EP300—prostate cancer	1.38e-05	0.000165	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ITPR1—prostate cancer	1.36e-05	0.000163	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SRC—prostate cancer	1.35e-05	0.000161	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOA2—prostate cancer	1.34e-05	0.00016	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.34e-05	0.00016	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A1—prostate cancer	1.34e-05	0.00016	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ERCC2—prostate cancer	1.33e-05	0.000158	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—prostate cancer	1.31e-05	0.000156	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TYMS—prostate cancer	1.29e-05	0.000154	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A5—prostate cancer	1.28e-05	0.000153	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTM1—prostate cancer	1.27e-05	0.000152	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2E1—prostate cancer	1.25e-05	0.000149	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LPL—prostate cancer	1.25e-05	0.000149	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—prostate cancer	1.25e-05	0.000149	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NQO1—prostate cancer	1.24e-05	0.000148	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARA—prostate cancer	1.22e-05	0.000146	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TH—prostate cancer	1.22e-05	0.000146	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.21e-05	0.000145	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A1—prostate cancer	1.21e-05	0.000144	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP3A4—prostate cancer	1.21e-05	0.000144	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—prostate cancer	1.2e-05	0.000144	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.2e-05	0.000143	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ERCC2—prostate cancer	1.2e-05	0.000143	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1B1—prostate cancer	1.19e-05	0.000142	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAV1—prostate cancer	1.15e-05	0.000137	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GGT1—prostate cancer	1.15e-05	0.000137	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOA1—prostate cancer	1.13e-05	0.000135	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—prostate cancer	1.12e-05	0.000134	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP19A1—prostate cancer	1.11e-05	0.000133	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—prostate cancer	1.11e-05	0.000133	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARA—prostate cancer	1.1e-05	0.000132	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.1e-05	0.000131	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RXRA—prostate cancer	1.08e-05	0.000128	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—prostate cancer	1.05e-05	0.000125	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.05e-05	0.000125	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAV1—prostate cancer	1.04e-05	0.000124	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—COMT—prostate cancer	1.04e-05	0.000124	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTP1—prostate cancer	1.03e-05	0.000123	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—prostate cancer	1.02e-05	0.000122	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ITPR1—prostate cancer	1.01e-05	0.000121	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.98e-06	0.000119	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—INS—prostate cancer	9.92e-06	0.000118	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.91e-06	0.000118	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—prostate cancer	9.9e-06	0.000118	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CREBBP—prostate cancer	9.71e-06	0.000116	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TYMS—prostate cancer	9.59e-06	0.000114	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—prostate cancer	9.48e-06	0.000113	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—prostate cancer	9.45e-06	0.000113	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LPL—prostate cancer	9.3e-06	0.000111	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—prostate cancer	9.21e-06	0.00011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A1—prostate cancer	8.98e-06	0.000107	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—INS—prostate cancer	8.95e-06	0.000107	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ERCC2—prostate cancer	8.91e-06	0.000106	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CREBBP—prostate cancer	8.76e-06	0.000105	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NOS3—prostate cancer	8.7e-06	0.000104	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—prostate cancer	8.38e-06	0.0001	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—prostate cancer	8.36e-06	9.98e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—prostate cancer	8.31e-06	9.92e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARA—prostate cancer	8.22e-06	9.81e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—prostate cancer	8.03e-06	9.58e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—prostate cancer	7.95e-06	9.49e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NOS3—prostate cancer	7.85e-06	9.37e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAV1—prostate cancer	7.73e-06	9.22e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.38e-06	8.81e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—prostate cancer	7.24e-06	8.65e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—prostate cancer	7.18e-06	8.57e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—prostate cancer	7.04e-06	8.4e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—prostate cancer	6.94e-06	8.28e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—INS—prostate cancer	6.66e-06	7.95e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—EP300—prostate cancer	6.61e-06	7.9e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CREBBP—prostate cancer	6.52e-06	7.79e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—prostate cancer	6.26e-06	7.47e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—prostate cancer	6.19e-06	7.39e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—EP300—prostate cancer	5.97e-06	7.13e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NOS3—prostate cancer	5.84e-06	6.97e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—prostate cancer	5.39e-06	6.44e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—prostate cancer	5.34e-06	6.38e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—prostate cancer	4.89e-06	5.84e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—prostate cancer	4.66e-06	5.56e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—EP300—prostate cancer	4.44e-06	5.31e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—prostate cancer	4.41e-06	5.27e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—prostate cancer	4e-06	4.77e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—prostate cancer	3.61e-06	4.31e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—prostate cancer	3.29e-06	3.92e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—prostate cancer	2.69e-06	3.21e-05	CbGpPWpGaD
